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Abstract
Background: The differentiation program of thyroid follicular cells (TFCs), by far the most abundant cell population of the
thyroid gland, relies on the interplay between sequence-specific transcription factors and transcriptional coregulators with
the basal transcriptional machinery of the cell. However, the molecular mechanisms leading to the fully differentiated
thyrocyte are still the object of intense study. The transcription factor Pax8, a member of the Paired-box gene family, has
been demonstrated to be a critical regulator required for proper development and differentiation of thyroid follicular cells.
Despite being Pax8 well-characterized with respect to its role in regulating genes involved in thyroid differentiation,
genomics approaches aiming at the identification of additional Pax8 targets are lacking and the biological pathways
controlled by this transcription factor are largely unknown.
Methodology/Principal Findings: To identify unique downstream targets of Pax8, we investigated the genome-wide effect
of Pax8 silencing comparing the transcriptome of silenced versus normal differentiated FRTL-5 thyroid cells. In total, 2815
genes were found modulated 72 h after Pax8 RNAi, induced or repressed. Genes previously reported to be regulated by
Pax8 in FRTL-5 cells were confirmed. In addition, novel targets genes involved in functional processes such as DNA
replication, anion transport, kinase activity, apoptosis and cellular processes were newly identified. Transcriptome analysis
highlighted that Pax8 is a key molecule for thyroid morphogenesis and differentiation.
Conclusions/Significance: This is the first large-scale study aimed at the identification of new genes regulated by Pax8, a
master regulator of thyroid development and differentiation. The biological pathways and target genes controlled by Pax8
will have considerable importance to understand thyroid disease progression as well as to set up novel therapeutic
strategies.
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Introduction
The thyroid is mainly composed of highly differentiated epithelial
cells known as thyroid follicular cells (TFC), that are devoted to the
production and export of thyroid hormones, such as thyroxine (T4)
and triodothyronine (T3), essential for growth, development and
survival. The differentiation program of thyroid follicular cells relies
on the interplay between transcription factors and transcriptional
coregulators with the basal transcriptional machinery. The
simultaneous and orchestrated expression of these proteins plays a
pivotal role in the control and maintenance of the differentiated
phenotype, determining the expression of a set of thyroid-specific
genes. Some of these genes, such as thyroglobulin (Tg) and
thyroperoxidase (TPO), are only expressed in thyroid cells; others,
such as sodium-iodide symporter (NIS), thyrotropin receptor
(TSHr), pendrin, Hex and thyroid oxidase (THOX) are much
more abundant in the thyroid as compared to other tissues [1,2].
Among the transcription factors involved in the expression of
thyroid-specific genes there is Pax8, a member of the Pax (Paired-
box) gene family [3]. Like other members of the family, Pax8 is
thought to orchestrate the patterns of gene expression in specific
cells during organ development. During thyroid development,
Pax8 is expressed upon transition from undifferentiated endoderm
cells to thyroid follicular fated cells in the thyroid anlage and
continues to be expressed throughout development and in the
adult gland [1]. It has been clearly demonstrated that Pax8 is
necessary for the expression of thyroid-specific genes, like
thyroglobulin (Tg), thyroperoxidase (TPO), and sodium/iodide
symporter (NIS) essential for the synthesis of active thyroid
hormones [4,5,6]. In addition, in Pax8 knockout mice the thyroid
gland is barely visible and lacks the follicular cells [7]. The critical
role exerted by Pax8 in TFC differentiation has been demonstrat-
ed also in cell culture systems. For example, in thyroid cells
expressing the polyoma virus middle T antigen (PCPy cells), loss of
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phenotype, measured as the expression of Tg, TPO and NIS
genes. Re-introduction of Pax8 in PCPy cells is sufficient to re-
activate the expression of the endogenous Tg, TPO and NIS genes
[5]. Given the pivotal role played by Pax8 in thyrocyte
differentiation, in the past years many studies have been focused
on the molecular mechanisms by which Pax8 modulates thyroid
gene expression. Recently, it has been demonstrated that Pax8
biochemically interacts with Titf1/Nkx2.1 and the interaction
between the two factors has an important functional relevance
since they strongly synergize in the transcriptional activation of
thyroid-specific genes [8]. Moreover, by using different experi-
mental strategies, two interesting partners of Pax8, PARP-1 and
TAZ, have been identified [9,10].
PAX8 mutations and inactivation are implicated in various
thyroid conditions. Congenital hypothyroidism is caused by
several genetic defects and among these there are mutations in
the PAX8 gene [1,11,12]. In addition to hypothyroidism, PAX8
plays a role also in the progression of follicular thyroid carcinomas
and adenomas [13,14]. In tissues other than the thyroid, PAX8
was found overexpressed in epithelial ovarian cancer [15] and it
has been hypothesized that PAX8 maybe an important regulator
of telomerase activity and cell survival in some gliomas [16].
Although the crucial role of Pax8 during development and
differentiation of thyroid cells has been well established, very little
is known about Pax8 target genes in these cells. Therefore, we
performed a genome-wide screening to identify novel Pax8 targets,
thus acquiring relevant information on molecular events control-
ling thyroid function.
Results
Gene expression profile changes upon knock-down of
Pax8
To identify genes regulated by Pax8 in differentiated thyroid
cells, FRTL-5 cells were transfected with siGENOME Pax8
siRNA (experimental) or siGENOME Non-Targeting siRNA
(control), a scrambled sequence that does not show homology
with any rat gene. RNAs extracted from the cells 72 h after
transfection were hybridized to the Affymetrix GeneChipH Rat
Gene 1.0 ST, a high density oligonucleotide array capable to
analyze 27,342 well-annotated rat genes. Data from three
independent silencing experiments were analyzed unraveling
2815 genes differentially expressed between silenced cells and
scramble controls, with fold change greater than 1.2 (FDR p
,0.05) (see Table S1). Of these, 1421 genes were down-regulated
and 1394 genes were up-regulated as shown by the Volcano Plot
representation (Figure 1). As expected, Pax8 was differentially
expressed in the two samples (fold decrease=1,7324) as were also
several already known Pax8 target genes (Table 1).
Gene ontology (GO) functional class scoring of the differentially
expressed genes demonstrated that the most affected categories
were: DNA replication, mitosis, nuclear division, M phase of
mitotic cell cycle, cell migration for the down-regulated genes
(Figure 2A) and transferase activity, mitochondrial outer mem-
brane, sulfur metabolic process, cofactor metabolic process for the
up-regulated genes (Figure 2B). Accordingly, the most affected
pathways were cell cycle, DNA replication, apoptosis for the
downregulated genes (Figure 2C) and arginine and proline
metabolism, pyrimidine metabolism, adipocytokine signaling
pathway, drug metabolism, lysosome for the upregulated ones
(Figure 2D).
Pathway express analysis of all the dysregulated genes
demonstrated that 19 pathways (Figure 3), including phosphati-
dylinositol signaling, adherens junction, MAPK signaling, cell
cycle, thyroid cancer as well as other cancer pathways, insulin
signaling, p53 signaling and apoptosis, were highly perturbed upon
silencing of Pax8.
Since the goal of the study was the identification of novel Pax8
targets in FRTL-5 cells, a strategy was developed to reduce the
number of false positive targets filtering data according to tissue
specificity and Transcription Factor Binding Sites (TFBSs)
conservation. Differentially expressed genes were filtered accord-
ing to their thyroid-enriched expression using the BioGps gene
annotation portal and the GeneHub Gepis bioinformatics tool. To
identify Pax8 direct targets, the filtered genes were analyzed for
the presence in their 5’-flanking regions of Pax8 binding consensus
sequences and were ranked according to their affinity score to
PAX8_01 and PAX8_B matrices $1.4 using the PASTAA
method [17]. This cutoff level was chosen in order to include all
the well-known Pax8 targets.
A total of 276 genes, 134 down-regulated and 142 up-regulated
upon Pax8 silencing, were selected (Table S2).
Validation of a set of genes dysregulated by Pax8
silencing
To validate the expression data obtained by the microarray
analysis, we performed qRT-PCR for 17 genes, 13 down-
regulated and 4 up-regulated, that were randomly chosen from
the ranked lists of Pax8 putative targets obtained by the PASTAA
analysis (Table 2). qRT-PCR on RNA samples prepared 72 h
after Pax8 siRNA transfection confirmed the microarray results for
all selected genes (Figure 4A). In particular, we identified Trib1,
Wnt4, Cdh16, Wbp2, Slc26a7, Igfbp7, Egr1, Nfkb1, Rab17, Kcnj16,
Kcnj15 as genes positively regulated by Pax8; Sparc, Cited2, TAZ and
Runx2 as genes negatively regulated by Pax8. Additionally, the
Figure 1. Volcano plot representation of dysregulated genes.
One way ANOVA test with Benjamini and Hochberg false discovery rate
(FDR) correction was applied to the comparison between the conditions
(siPax8 vs. controls), using a 0.05 threshold for statistical significance.
The negative log10-transformed p-values are plotted against the log
ratios (log2 fold change) between conditions. Red dots represent
differentially expressed genes that show both large fold changes and
high statistical significance. Gray dots represent all the other genes.
doi:10.1371/journal.pone.0025162.g001
Pax8 Gene Profiling
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Gene symbol Gene description Fold change Reference
Tg thyroglobulin 23,35028 [8,24]
Slc5a5 solute carrier family 5 (sodium iodide symporter), member 22,07442 [6]
TPO thyroperoxidase 21,94253 [8]
Hhex hematopoietically expressed homeobox 21,7037 [4]
Foxe1 forkhead box E1 (thyroid transcription factor 2) 21,48761 [24]
Duox2 dual oxidase 2 21,15531 [24]
doi:10.1371/journal.pone.0025162.t001
Figure 2. Functional class scoring of the differentially expressed genes. Gene ontology (GO) and pathway functional class scoring have
been performed using the Gene Set Analysis Toolkit V2 (http://bioinfo.vanderbilt.edu/webgestalt). A) GO categories enriched for genes down-
regulated after Pax8 silencing. B) GO categories enriched for genes up-regulated after Pax8 silencing. C) KEGG (Kyoto Encyclopedia of Genes and
Genomes) pathways enriched for genes down-regulated after Pax8 silencing. D) KEGG pathways enriched for genes up-regulated after Pax8 silencing.
doi:10.1371/journal.pone.0025162.g002
Pax8 Gene Profiling
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[6,18] was confirmed thus indicating that the experiment was well
performed and the expression data are reliable.
To test whether Pax8 was directly involved in the transcrip-
tional regulation of the validated genes, the effect of Pax8 silencing
on their expression 24 h after siRNA transfection was evaluated.
This time point was chosen because the half-life of the Pax8
protein was found to be approximately 16 h (our unpublished
data). Eleven transcripts responded significantly to Pax8 silencing
24 h after siRNA transfection (Figure 4B), and these were Trib1,
Wnt4, Cdh16, Rab17, Kcnj16, Tg and Foxe1 which were downreg-
ulated and Sparc, Cited2, TAZ and Runx2 which were upregulated.
To unambiguously determine whether Pax8 regulated these
genes by directly binding to their regulative genomic sequences, a
computational analysis using the MatInspector Software 8.0 was
performed. We searched for Pax8 binding sites in a region of
about 3000 bp in their 5’-flanking region, and the analysis showed
the presence of Pax8 consensus sequences in all the genomic
regions analyzed. To confirm the predictions of the MatInspector
analysis, chromatin immunoprecipitation (ChIP) assays on FRTL-
5 cells was carried out. The cross-linked chromatin was
immunoprecipitated using a polyclonal antibody against Pax8.
As control, to rule out unspecific background of the ChIP assay,
one reaction lacking the primary antibody was performed. For
each gene, 2 or 3 pairs of oligonucleotides to amplify two or three
genomics regions upstream the coding sequences were designed.
The sequences of the oligonucleotides that showed positive results
are reported in Table S3. In line with our previous results, we
demonstrated the binding of Pax8 to the 5’-flanking region of all
the genes modulated by Pax8 silencing already 24 h after siRNA
transfection (Figure 5). Furthermore, in agreement with our
published data [18], Pax8 antibody was able to immunoprecipitate
the chromatin containing the Tg and Foxe1 gene promoters
(Figure 5).
In conclusion, we identified new Pax8 binding sites in the 5’-
flanking regions of Trib1, Wnt4, Cdh16, Rab17, Kcnj16, genes that
are downregulated 24 h after Pax8 silencing, and of Sparc, Cited2,
TAZ, Runx2, genes that are upregulated 24 h after Pax8 silencing,
suggesting that these genes are direct downstream targets of this
transcription factor.
Discussion
It is well established that the transcription factor Pax8 plays a
crucial role in thyroid phenotype determination, thyroid develop-
ment and differentiation [3,5]. In order to define the transcrip-
tional network functionally regulated by Pax8 as well as infer its
direct targets, we performed RNAi to knock-down Pax8 gene in
FRTL-5 thyroid cells and we analyzed the gene expression profile
by microarray analysis. The results obtained suggest that Pax8
regulates several pathways, mainly involved in the regulation of
cell cycle, thyroid cancer and apoptosis (Figure 3), thus confirming
that Pax8 is a master regulatory gene. Among the genes that we
validated there are Cited2, TAZ, Runx2, Trib1, Sparc, Wnt4, Rab17,
Kcnj16 and Cdh16. We have chosen these genes from both the
downregulated and upregulated ranked lists of genes according to
their expression in fetal or adult thyroid and predicted affinity of
their 5’-flanking regions to Pax8 binding. Moreover, these genes
are included in the most represented gene categories such as
regulation of cell transcription, regulation of cell proliferation,
organ development, signal transduction, cell migration and
regulation of localization.
Cited2, TAZ, Runx2 and Trib1 belong to the categories of
regulation of cell transcription and cell proliferation.
Cited2 (CBP/p300 interacting coactivator with glutamic acid/
aspartic acid-rich tail 2) is a bifunctional protein, critical for the
regulation of various cellular processes, especially cell growth and
oncogenesis. Initially described as a corepressor of hypoxia-
Figure 3. Pathway analysis of genes differentially expressed in siPax8 vs. controls. Pathway-Express software was used to identify the
pathways most affected by the gene dysregulation. The histograms represent affected pathways ranked according to the impact factor, an index that
measures the pathway perturbation [56].
doi:10.1371/journal.pone.0025162.g003
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[19], it also functions as a coactivator of AP-2 and PPARa and
PPARc by recruiting CBP/p300 [20,21]. In the literature,
different observations suggest that Cited2 may be a pro-apoptotic
factor [22], but it may also have anti-apoptotic properties [23].
Thus, the transcriptional regulation of Cited2 by Pax8 could play
an important role in the regulation of cell growth and survival.
TAZ, also known as Wwtr1, was recently identified as a
transcriptionalco-activatorof varioustranscription factors, including
Runx2/Cbfa1 [24,25], the TEF-1 gene family [26], TBX5 [27],
Pax3 [28], TTF-1 [29]. Recently, we have demonstrated that TAZ
acts as a potent regulator of Pax8 and TTF-1 activity [9] and we
have also reported that TAZ, already known to promote cell
proliferation and to induce epithelial–mesenchymal transition [30],
is overexpressed in papillary thyroid cancer [31]. Our findings here
presented suggest that Pax8 could directly regulate TAZ expression,
in addition to physically interact with it to control finely thyroid
development and differentiation. It is worth to underline that TAZ
plays a crucial role in mesenchymal stem cell differentiation by
promoting osteoblast differentiation [25] and in this process TAZ
functions as a coactivator of Runx2, an osteoblast-specific
transcription factor. Interestingly, Runx2 and TAZ have been found
over-expressed in thyroid papillary carcinoma [31,32] and respon-
sible for calcification processes present in these tumor tissues.
Moreover, it has been recently demonstrated that Runx2 deficiency
in mice causes decreased thyroglobulin expression [33]. All together,
our data suggest that both TAZ and Runx2 are direct targets of Pax8,
thus it will be of great interest to investigate the effect of TAZ and
Runx2 over-expression or silencing with respect to thyroid cells
proliferation and differentiation.
Trib1 is a member of a recently identified protein family called
tribbles, that function as dynamic interactors of MAPK proteins,
regulating numerous signaling pathways that play a role in
embryonic development and the development of human diseases,
such as cancer and autoimmune disease [34].
Finally, also involved in the regulation of cell proliferation there
is the gene Sparc. Also named osteonectin or BM-40, it is a
membrane-associated glycoprotein, which governs diverse cellular
functions and has a pivotal role in regulating cell-matrix
interactions, cellular proliferation and migration [35,36]. Sparc
plays as an important role in controlling malignancy of ovarian
carcinoma [37] and during hypothalamic neuroendocrine cells
development [38]. Recently, it has been demonstrated that Sparc is
directly regulated by TTF-1/Nkx2.1 in Gonadotropin-Releasing
Hormone (GRH) neurons [39]. TTF-1 (T-EBP/Nkx2.1) is a
member of the Nkx-2 subfamily, originally identified as a protein
able to bind to a DNA sequence that is present three times on both
the Tg and the TPO promoters [40,41]. We have, recently,
demonstrated that the simultaneous expression of Pax8 and TTF-
1 in thyroid cells has an important functional relevance since they
strongly synergize in the transcriptional activation of thyroid-
specific genes [8]. Interestingly, our data together with the already
published evidences suggest that a cooperative regulation of Sparc
expression by both transcription factors Pax8 and TTF-1 is likely
to occur, strengthening the hypothesis of the existence of a
transcriptional network that allows the fine-tuning of thyroid-
specific gene expression involved in thyroid development and
differentiation.
Among the genes belonging to the signal transduction category
there is Wnt4. Initially classified as a non-canonical Wnt protein, it
has been described to activate also the canonical signaling
pathway. Wnt4 knockdown underlined its crucial role in the
development of several organ such as kidney, ovary, and
mammary gland [42,43,44]. Mice lacking Wnt4 die after birth
Table 2. Genes differentially expressed in siPax8 cells versus siNon-targeting cells selected by the PASTAA analysis.
Common Synonyms ENTREZ Gene ID Affinity Score
Down-regulated genes
Rab17 RAB17, member RAS oncogene family 503269 2.07
Slc26a7 Solute carrier family 26, member 7 297910 2.05
Trib1 Tribbles homolog 1 (Drosophila) 78969 1.98
Wnt4 Wingless-type MMTV integration site family, member 4 84426 1.93
Tg Thyroglobulin 24826 1.92
Kcnj16 Potassium inwardly-rectifying channel, subfamily J, member 16 29719 1.88
Kcnj15 Potassium inwardly-rectifying channel, subfamily J, member 15 170847 1,84
Igfbp7 Insulin-like growth factor binding protein 7 289560 1.79
Nfkb1 Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 81736 1.79
Egr1 Early growth response 1 24330 1.78
Cdh16 Cadherin 16, KSP-cadherin 307614 1.71
Wbp2 WW domain binding protein 2 192645 1.61
Foxe1 Forkhead box E1 (thyroid transcription factor 2) 192274 1.40
Up-regulated genes
Runx2 Runt-related transcription factor 2 367218 2.28
Cited2 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 114490 1.95
TAZ transcriptional co-activator with PDZ-binding motif 295062 1.93
Sparc secreted protein, acidic, cysteine-rich glycoprotein 24791 1.68
All the genes are modulated at least 1.3 fold with a p2value,0.05. We show 13 genes down-regulated and 4 genes up-regulated with affinity score to PAX8$1.40,
selected for further analysis. The genes reported in bold are the ones validated by qPCR after 24 h siRNA transfection.
doi:10.1371/journal.pone.0025162.t002
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demonstrated that Pax2, another member of the Pax gene family,
is able to activate Wnt4 promoter activity in a proximal tubule cell
line promoting nephrogenesis [45]. At the same time, a
cooperative role for Pax2 and Pax8 in metanephric branching
morphogenesis and nephron differentiation has been uncovered
[46]. Pax8 is required for the morphogenesis of the thyroid gland
[7] and for the maintenance of the thyroid-differentiated
phenotype [5]. Thus, it will be interesting to further analyze the
potential function of Pax8/Wnt4 pathway during thyroid
differentiation. In addition, the non-canonical pathway is crucial
for the migration and also plays an important role in tumor
biology [47]. Osamura group’s suggested that Wnt4/Fzd6
signaling is activated through the b-catenin-independent pathway
in GHoma and TSHoma [48]. Together these findings suggest a
potential involvement of Pax8/Wnt4 during the migration of the
thyroid primordium and/or later on during development when
the gland reaches its definitive position.
Some of the genes modulated by Pax8 belong to the protein and
ion transport categories. The small GTPase, Rab17, a member of
the rab family of regulators of intracellular transport, here
identified as a novel Pax8 target, plays an important role in the
control of transport through the apical recycling endosome and in
the regulation of polarized membrane sorting [49].
Kcnj16 (inward rectifier K+ channel subunit, also named Kir5.1)
is involved in the regulation of fluid and pH balance. The analysis
of Kcnj16
2/2 mice highlighted its crucial role in defining neuronal
pH sensitivity [50]. Interestingly, our data indicated Kcnj16 as a
direct target of Pax8, suggesting that Pax8 may act on K+ channel
level to regulate thyroid growth and function. At the same time, it
Figure 4. Validation of the microarray results by qRT-PCR. Transcript abundance of 17 selected genes was measured by qRT-PCR. Relative
gene expression in siPax8 transfectants was calculated using non-targeting siRNA transfectant RNA (Ctrl) as reference. A) Differential gene expression
in siPax8 vs Ctrl cells, 72 h after Pax8 silencing: comparison between qRT-PCR and array data validates array results with a correlation coefficient r .
0.80. B) Differential gene expression in siPax8 vs Ctrl cells, 24 h after Pax8 silencing. The experiment was repeated three times on different biological
replicates. White bars indicate differentially expressed genes with absolute fold change.1.2 and high statistical significance (p,0.05 for t-test). These
genes are presumably direct Pax8 targets. In both panels, the fold change of Pax8 expression level is shown in the insert.
doi:10.1371/journal.pone.0025162.g004
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guaranteed by the ability of the polarized epithelial cells to
maintain the specific biochemical composition of the apical and
basolateral plasma membrane domains.
Among the Pax8 novel targets unraveled in this study, we have
identified the Cdh-16 gene that belongs to the cell adhesion
category. Cadherin-16, also named Ksp-cadherin, represents a
structurally distinct member of the cadherins family. It belongs to
a new subfamily of cadherins termed the 7D-cadherins, which are
mainly characterized by two structural features: seven extracellular
cadherin repeat domains (EC) and a highly truncated cytoplasmic
tail. Identified as the only tissue-specific cadherin expressed
exclusively in the kidney [51], it has been recently detected on
the plasma membrane of human and mouse thyrocytes [52]. The
long distance between the final location of the thyroid gland in
front of trachea and the site of embryological specification at
tongue base suggest that thyroid development could be influenced
by cadherins, a superfamily of cell-cell adhesion molecules
involved in migration, sorting, and re-aggregation of cells during
embryogenesis [53]. Interestingly, the expression profile of cadherin-
16 resembles that of the transcription factor Pax8, making this
adhesion molecule an excellent candidate to be a target of Pax8.
In this manuscript, we propose and discuss an overview of the
genes potentially regulated by Pax8 in FRTL-5 cells inferred from
the list of the differentially expressed genes in the microarray
analysis. We identify potential Pax8 targets based on changes in
transcripts levels, on the presence of Pax8 binding site(s) in their 5’-
flanking sequences and tissue-specificity. We believe that our
approach shows a great potentiality; in fact, we have been able to
demonstrate that the majority (11 out of 17) of the genes that we
have selected among the predicted Pax8 targets are indeed targets
of this transcription factor. Therefore, it is likely that in the list of
276 genes that resulted from the PASTAA analysis there are many
other interesting Pax8 targets to be further analyzed. Possibly, a
more massive validation approach could take off a number of
target genes almost comparable to a genome-wide ChIP-on-chip
assay, which yet requires the availability of good specific
antibodies.
Furthermore, this study shows that Pax8 is involved in the
regulation of a large number of genes in differentiated FRTL-5
cells that will need to be evaluated by further studies to fully
ascertain Pax8 direct targets. Although the broadness of the group
of genes that could be regulated by Pax8 is consistent with its
already known role of master regulator, it has highlighted several
biological pathways downstream of this transcription factor that
encourage further investigation of Pax8 function in new cellular
processes.
Materials and Methods
Cell culture
The rat thyroid FRTL-5 cell line was used for this study
(ATCC, cat. CRL-1468). FRTL-5 cells were grown in Coon’s
modified F-12 medium (Euroclone) supplemented with 5% calf
serum and a six-hormone mixture (6 H) as described by Ambesi-
Impiombato and Coon [54].
RNA interference
FRTL-5 cells were plated (8610
4 well) in 24-well plate and were
transfected in triplicate with 100 nM Pax8 siGENOME siRNA or
siGENOME Non-Targeting #3 (DHARMACON) as scramble
using DharmaFECT 1 transfection reagent, following the
manufacturer’s protocol. Sequences corresponding to the siRNA
of Pax8 were sense, 5’-CCAUAUUAUUACAGCUCUA-3’; and
antisense, 5’-UAGAGCUGUAAUAAUAUGG-3’. Cells were
harvested 24 and 72 h after transfection and the total RNA was
extracted.
RNA extraction, quantitative real time RT–PCR and
microarray hybridization
Total RNA was extracted using TRIzol reagent (Invitrogen) and
treated with RNase-free DNase I (Applied Biosystem) for both
qRT-PCR and microarray analyses.
For qRT-PCR the cDNA was synthesized using iScript cDNA
Synthesis kit (BIORAD, Hercules, CA). Real time RT–PCR
analysis was performed using IQ
TM SYBR Green PCR Master
Mix (BIORAD) in an iCycler IQ
TM real-time detection system
(BIORAD).
For microarray analysis, 5mg of total RNA extracted 72 h after
transfection, were sent to the Affymetrix Microarray Unit at
IFOM-IEO, Milan (http://www.cogentech.it) for labeling, ampli-
fication and hybridization to the AffymetrixGeneChip Rat Gene
1.0 ST array, according to manufacturer’s protocols. Three
independent silencing experiments were performed from which
three biological replicates of each condition (siPax8 or control)
were processed for microarray analysis.
Figure 5. ChIP experiments for Pax8 binding to predicted
targets. Chromatin Immunoprecipitation performed on FRTL-5 cells
with Pax8 antibody followed by PCR analysis of 11 predicted Pax8
targets shows the binding in vivo of Pax8 to the 5’-flanking regions of
these genes.
doi:10.1371/journal.pone.0025162.g005
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Array images have been preprocessed into CEL files using
Affymetrix specific softwares. Gene-level signals were generated
from CEL files with GeneSpring v.11.5 software (Agilent
Technologies Inc.), using the Probe Logarithmic Intensity Error
(PLIER) summarization algorithm, as recommended by Affyme-
trix protocols (http://www.affymetrix.com/support/technical/
technotes/plier_technote.pdf).
After filtering genes with raw expression values lower than 20,
differentially expressed genes, with a fold change higher than 1.2
in siPax8 vs. controls, were selected by one way ANOVA test and
Benjamini and Hochberg false discovery rate (FDR) correction,
using a 0.05 threshold for statistical significance.
All data is MIAME compliant and the raw data has been
deposited in the MIAME compliant database Gene Expression
Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) (accession
n. GSE29341).
Functional analysis
Gene ontology (GO) and pathway functional class scoring have
been performed using the Gene Set Analysis Toolkit V2 (http://
bioinfo.vanderbilt.edu/webgestalt) [55]. Using the Pathway-Ex-
press software (ONTO-tools, http://vortex.cs.wayne.edu/pro-
jects.htm) [56], the pathways most affected by the gene
dysregulation were ranked according to the impact factor of the
entire pathway, a probabilistic term that takes into consideration
the proportion of differentially regulated genes in the pathway and
therefore the pathway perturbation.
Analysis of transcription factor binding sites (TFBSs)
The promoter regions of genes coregulated after Pax8 silencing
were analyzed in order to recognize DNA binding motifs for both
PAX8_01 and PAX8_B matrices (from TRANSFAC database). A
strategy was developed to reduce the number of false positive
targets filtering data according to tissue specificity and TFBSs
conservation. Genes differentially expressed in siPax8 vs. controls
were ranked according to their specific expression in thyroid tissue,
using the BioGps gene annotation portal (http://biogps.gnf.org)
[57] and the GeneHub Gepis bioinformatics tool (http://www.cgl.
ucsf.edu/Research/genentech/genehub-gepis). Genes mostly ex-
pressed in either fetal or adult thyroid were selected for the TFBS
analysis using the web-based PASTAA (predicting associated
transcription factors from annotated affinities) method (http://
trap.molgen.mpg.de) [17], which utilizes the prediction of binding
affinities of a TF to promoters. The lists of downregulated and
upregulated genes were ranked respectively according to the
prediction of binding affinity of their promoter regions to the
PAX8 binding sites, with the following criteria: range for promoter
region from -10000 to 0 at either side of the transcription start site,
conserved mouse/human sequence block, maximum affinity
across promoter range.
ChIP assay
Genomic sequences including 3 kb upstream of the start codon
were retrieved from Genome website (http://www.genome.ucsc.
edu) and were explored to predict potentially transcription factor
binding sites using GEMS, Genomatix software (http://www.
genomatix.de).
Chromatin immunoprecipitation (ChIP) was performed as
follows. The cross-linking solution, containing 1% formaldehyde,
was added directly to cell culture media. The fixation proceeded
for 10 min and was stopped by the addition of glycine to a final
concentration of 125 mM. FRTL-5 cells were rinsed twice with
cold PBS plus 1 mM PMSF, and then scraped. Cells were
collected by centrifugation at 8006g for min at 4 C. Cells were
swelled in cold cell lysis buffer containing 5 mM piperazine-N,N-
bis(2-ethanesulfonic acid) (pH 8.0), 85 mM KCl, 0.5% Nonidet P-
40, 1 mM PMSF, and inhibitors cocktail (Sigma) and incubated
on ice for 10 min. Nuclei were spun down by microcentrifugation
at 20006g for 5 min at 4 C, resuspended in nuclear lysis buffer
containing 50 mM Tris-HCl (pH 8), 10 mM EDTA, 0.8% sodium
dodecyl sulfate (SDS), 1 mM PMSF and inhibitors cocktail
(Sigma), and then incubated on ice for 10 min. Samples were
broken by sonication into chromatin fragments of an average
length of 500/1000 bp and then microcentrifuged at 16,0006g.
The sonicated cell supernatant was diluted 8-fold in ChIP Dilution
Buffer containing 0.01% SDS, 1.1% Triton X-100, 1.2 mM
EDTA, 16.7 mM Tris-HCl (pH 8.1), and 167 mM NaCl, and
precleared by adding Salmon Sperm DNA/Protein A Agarose
(Upstate Biotechnology, Inc., Lake Placid, NY) for 30 min at 4 C.
Precleared chromatin from 1610
6 cells was incubated with 1 mgo f
affinity-purified rabbit polyclonal antibody anti-Pax8 (kindly
provided by Prof. R. Di Lauro), or no antibody and rotated at 4
C for 16 h. Immunoprecipitates were washed five times with RIPA
buffer containing 10 mM Tris-HCl (pH 8), 1 mM EDTA, 1%
Triton X-100, 0.1% Na-deoxycholate, 0.1% SDS, 140 mM NaCl,
and 1 mM PMSF; twice with LiCl buffer containing 0.25 M LiCl,
1% Nonidet P-40, 1% Na-deoxycholate, 1 mM EDTA, 10 mM
Tris-HCl (pH 8.0), and then three times with TE (10 mM Tris-
HCl, pH 8; 1 mM EDTA). Before the first wash, the supernatant
from the reaction lacking primary antibody was saved as total
input of chromatin and was processed with the eluted immuno-
precipitates beginning at the cross-link reversal step. Immunopre-
cipitates were eluted by adding 1% SDS, 0.1 M NaHCO3 and
reverse cross-linked by addition of NaCl to a final concentration of
200 mM and by heating at 65 C for 16 h. Recovered material was
treated with proteinase K, extracted with phenol-chloroform-
isoamyl alcohol (25:24:1) and precipitated. The pellets were
resuspended in 30 ml of TE and analyzed by PCR using specific
primers for the analyzed regions. The input sample was
resuspended in 30 ml of TE and diluted 1:10 before PCR.
Supporting Information
Table S1 The list of 2815 genes differentially expressed
siPax8 vs. controls with more than 1.2 absolute fold
change and p ,0.05.
(XLS)
Table S2 Lists of genes downregulated and upregulated
by Pax8 silencing, that are mostly expressed in either
fetal or adult thyroid, ranked according to the predic-
tion of the affinity of their 5’-flanking regions to PAX8
consensus binding sequence.
(XLS)
Table S3 Oligonucleotide primers used in ChIP assays.
(PDF)
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